Initiation of immune tolerance-controlled HIV gp41 neutralizing B cell lineages

Science Translational Medicine

Volumn 8, Issue 336, 2016, Pages

  Zhang, Ruijun ^a   Verkoczy, Laurent ^a   Wiehe, Kevin ^a   Alam, S Munir ^a   Nicely, Nathan I ^a   Santra, Sampa ^b   Bradley, Todd ^a   Pemble, Charles W ^a   Zhang, Jinsong ^a   Gao, Feng ^a   Montefiori, David C ^a   Bouton Verville, Hilary ^a   Kelsoe, Garnett ^a   Larimore, Kevin ^c,e   Greenberg, Phillip D ^c   Parks, Robert ^a   Foulger, Andrew ^a   Peel, Jessica N ^a   Luo, Kan ^a   Lu, Xiaozhi ^a   Trama, Ashley M ^a   Vandergrift, Nathan ^a   Tomaras, Georgia D ^a   Kepler, Thomas B ^d   Moody, M Anthony ^a   Liao, Hua Xin ^a   Haynes, Barton F ^a   more..

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BIOMARIN PHARMACEUTICAL INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 41; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOGLOBULIN M; NEUTRALIZING ANTIBODY; PROTEIN ANTIBODY; EPITOPE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY AFFINITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CELL LINEAGE; CLONAL ANERGY; CONTROLLED STUDY; FEMALE; GERM LINE; HEAVY CHAIN COMPLEMENTARITY DETERMINING REGION 3 HYDROPHOBICITY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROPHOBICITY; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; MACACA; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; STRUCTURE ANALYSIS; VACCINATION; VIRUS CELL INTERACTION; VIRUS NEUTRALIZATION; ANIMAL; GENETICS; IMMUNOLOGY; METABOLISM; MUTANT MOUSE STRAIN; RHESUS MONKEY;

AIDS VACCINES; ANIMALS; ANTIBODIES, NEUTRALIZING; B-LYMPHOCYTES; CELL LINEAGE; EPITOPES; EPITOPES, B-LYMPHOCYTE; FEMALE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP41; HIV INFECTIONS; IMMUNOGLOBULIN M; MACACA MULATTA; MALE; MICE; MICE, MUTANT STRAINS;

EID: 84964837055     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aaf0618     Document Type: Article

References (74)

1. J. R. Mascola, B. F. Haynes, HIV-1 neutralizing antibodies: Understanding nature's pathways. Immunol. Rev. 254, 225-244 (2013).
2. D. R. Burton, J. R. Mascola, Antibody responses to envelope glycoproteins in HIV-1 infection. Nat. Immunol. 16, 571-576 (2015).
3. P. Dosenovic, L. von Boehmer, A. Escolano, J. Jardine, N. T. Freund, A. D. Gitlin, A. T. McGuire, D. W. Kulp, T. Oliveira, L. Scharf, J. Pietzsch, M. D. Gray, A. Cupo, M. J. van Gils, K.-H. Yao, C. Liu, A.Gazumyan,M. S. Seaman, P. J. Björkman, R. W. Sanders, J. P. Moore, L. Stamatatos, W. R. Schief, M. C. Nussenzweig, Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice. Cell 161, 1505-1515 (2015).
4. J. G. Jardine, T. Ota, D. Sok, M. Pauthner, D. W. Kulp, O. Kalyuzhniy, P. D. Skog, T. C. Thinnes, D. Bhullar, B. Briney, S. Menis, M. Jones, M. Kubitz, S. Spencer, Y. Adachi, D. R. Burton, W. R. Schief, D. Nemazee, Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen. Science 349, 156-161 (2015).
5. R. W. Sanders, M. J. van Gils, R. Derking, D. Sok, T. J. Ketas, J. A. Burger, G. Ozorowski, A. Cupo, C. Simonich, L. Goo, H. Arendt, H. J. Kim, J. H. Lee, P. Pugach, M. Williams, G. Debnath, B. Moldt, M. J. van Breemen, G. Isik, M. Medina-Ramírez, J. W. Back, W. C. Koff, J.-P. Julien, E. G. Rakasz, M. S. Seaman, M. Guttman, K. K. Lee, P. J. Klasse, C. LaBranche, W. R. Schief, I. A.Wilson, J. Overbaugh, D. R. Burton, A. B. Ward, D. C. Montefiori, H. Dean, J. P. Moore, HIV-1 neutralizing antibodies induced by native-like envelope trimers. Science 349, aac4223 (2015).
6. J. K. Hu, J. C. Crampton, A. Cupo, T. Ketas, M. J. van Gils, K. Sliepen, S. W. de Taeye, D. Sok, G. Ozorowski, I. Deresa, R. Stanfield, A. B. Ward, D. R. Burton, P. J. Klasse, R. W. Sanders, J. P. Moore, S. Crotty, Murine antibody responses to cleaved soluble HIV-1 envelope trimers are highly restricted in specificity. J. Virol. 89, 10383-10398 (2015).
7. W. B. Williams, H.-X. Liao, M. A. Moody, T. B. Kepler, S. M. Alam, F. Gao, K. Wiehe, A. M. Trama, K. Jones, R. Zhang, H. Song, D. J. Marshall, J. F. Whitesides, K. Sawatzki, A. Hua, P. Liu, M. Z. Tay, K. E. Seaton, X. Shen, A. Foulger, K. E. Lloyd, R. Parks, J. Pollara, G. Ferrari, J.-S. Yu, N. Vandergrift, D. C. Montefiori, M. E. Sobieszczyk, S. Hammer, S. Karuna, P. Gilbert, D. Grove, N. Grunenberg, M. J. McElrath, J. R. Mascola, R. A. Koup, L. Corey, G. J. Nabel, C. Morgan, G. Churchyard, J. Maenza, M. Keefer, B. S. Graham, L. R. Baden, G. D. Tomaras, B. F. Haynes, Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies. Science 349, aab1253 (2015).
8. A. T.McGuire, S. Hoot, A. M. Dreyer, A. Lippy, A. Stuart, K.W. Cohen, J. Jardine, S.Menis, J. F. Scheid, A. P. West, W. R. Schief, L. Stamatatos, Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies. J. Exp.Med. 210, 655-663 (2013).
9. H.-X. Liao, R. Lynch, T. Zhou, F. Gao, S. M. Alam, S. D. Boyd, A. Z. Fire, K. M. Roskin, C. A. Schramm, Z. Zhang, J. Zhu, L. Shapiro; NISC Comparative Sequencing Program, J. C. Mullikin, S. Gnanakaran, P. Hraber, K. Wiehe, G. Kelsoe, G. Yang, S.-M. Xia,D. C. Montefiori, R. Parks, K. E. Lloyd, R. M. Scearce, K. A. Soderberg, M. Cohen, G. Kamanga, M. K. Louder, L. M. Tran, Y. Chen, F. Cai, S. Chen, S. Moquin, X. Du, M. G. Joyce, S. Srivatsan, B. Zhang, A. Zheng, G. M. Shaw, B. H. Hahn, T. B. Kepler, B. T. M. Korber, P. D. Kwong, J. R. Mascola, B. F. Haynes, Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 496, 469-476 (2013).
10. B. F. Haynes, J. Fleming, E. W. St. Clair, H. Katinger, G. Stiegler, R. Kunert, J. Robinson, R.M. Scearce, K. Plonk, H. F. Staats, T. L. Ortel, H.-X. Liao, S. M. Alam, Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308, 1906-1908 (2005).
11. G. Yang, T. M. Holl, Y. Liu, Y. Li, X. Lu, N. I. Nicely, T. B. Kepler, S. M. Alam, H.-X. Liao, D. W. Cain, L. Spicer, J. L. VandeBerg, B. F. Haynes, G. Kelsoe, Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies. J. Exp. Med. 210, 241-256 (2013).
12. M. Liu, G. Yang, K. Wiehe, N. I. Nicely, N. A. Vandergrift, W. Rountree, M. Bonsignori, S. M. Alam, J. Gao, B. F. Haynes, G. Kelsoe, G. Silvestri, Polyreactivity and autoreactivity among HIV-1 antibodies. J. Virol. 89, 784-798 (2015).
13. S. M. Alam, M. Morelli, S. M. Dennison, H.-X. Liao, R. Zhang, S.-M. Xia, S. Rits-Volloch, L. Sun, S. C. Harrison, B. F. Haynes, B. Chen, Role of HIV membrane in neutralization by two broadly neutralizing antibodies. Proc. Natl. Acad. Sci. U.S.A. 106, 20234-20239 (2009).
14. S. M. Alam, M. McAdams, D. Boren, M. Rak, R. M. Scearce, F. Gao, Z. T. Camacho, D. Gewirth, G. Kelsoe, P. Chen, B. F. Haynes, The role of antibody polyspecificity and lipid reactivity in binding of broadly neutralizing anti-HIV-1 envelope human monoclonal antibodies 2F5 and 4E10 to glycoprotein 41 membrane proximal envelope epitopes. J. Immunol. 178, 4424-4435 (2007).
15. J. Chen, G. Frey, H. Peng, S. Rits-Volloch, J. Garrity, M. S. Seaman, B. Chen, Mechanism of HIV-1 neutralization by antibodies targeting a membrane-proximal region of gp41. J. Virol. 88, 1249-1258 (2014).
16. Z.-Y. J. Sun, K. J. Oh, M. Kim, J. Yu, V. Brusic, L. Song, Z. Qiao, J.-h. Wang, G. Wagner, E. L. Reinherz, HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane. Immunity 28, 52-63 (2008).
17. L. Verkoczy, Y. Chen, J. Zhang, H. Bouton-Verville, A. Newman, B. Lockwood, R. M. Scearce, D. C. Montefiori, S. M. Dennison, S.-M. Xia, K.-K. Hwang, H.-X. Liao, S. M. Alam, B. F. Haynes, Induction of HIV-1 broad neutralizing antibodies in 2F5 knock-in mice: Selection against membrane proximal external region-associated autoreactivity limits T-dependent responses. J. Immunol. 191, 2538-2550 (2013).
18. J. Guenaga, R. T. Wyatt, Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function. PLOS Pathog. 8, e1002806 (2012).
19. S. M. Dennison, S. M. Stewart, K. C. Stempel, H.-X. Liao, B. F. Haynes, S. M. Alam, Stable docking of neutralizing human immunodeficiency virus type 1 gp41 membrane-proximal external region monoclonal antibodies 2F5 and 4E10 is dependent on the membrane immersion depth of their epitope regions. J. Virol. 83, 10211-10223 (2009).
20. Y. Chen, J. Zhang, K.-K. Hwang, H. Bouton-Verville, S.-M. Xia, A. Newman, Y.-B. Ouyang, B. F. Haynes, L. Verkoczy, Common tolerance mechanisms, but distinct cross-reactivities associated with gp41 and lipids, limit production of HIV-1 broad neutralizing antibodies 2F5 and 4E10. J. Immunol. 191, 1260-1275 (2013).
21. J. Zhang, S. M. Alam, H. Bouton-Verville, Y. Chen, A. Newman, S. Stewart, F. H. Jaeger, D. C. Montefiori, S. M. Dennison, B. F. Haynes, L. Verkoczy, Modulation of nonneutralizing HIV-1 gp41 responses by an MHC-restricted TH epitope overlapping those of membrane proximal external region broadly neutralizing antibodies. J. Immunol. 192, 1693-1706 (2014).
22. L. Verkoczy, Y. Chen, H. Bouton-Verville, J. Zhang, M. Diaz, J. Hutchinson, Y.-B. Ouyang, S. M. Alam, T. M. Holl, K.-K. Hwang, G. Kelsoe, B. F. Haynes, Rescue of HIV-1 broad neutralizing antibodyexpressing B cells in 2F5 VH × VL knockin mice reveals multiple tolerance controls. J. Immunol. 187, 3785-3797 (2011).
23. L. Verkoczy, M. Diaz, T. M. Holl, Y.-B. Ouyang, H. Bouton-Verville, S. M. Alam, H.-X. Liao, G. Kelsoe, B. F. Haynes, Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance. Proc. Natl. Acad. Sci. U.S.A. 107, 181-186 (2010).
24. B.-J. Ma, S. M. Alam, E. P. Go, X. Lu, H. Desaire, G. D. Tomaras, C. Bowman, L. L. Sutherland, R. M. Scearce, S. Santra, N. L. Letvin, T. B. Kepler, H.-X. Liao, B. F. Haynes, Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies. PLOS Pathog. 7, e1002200 (2011).
25. C. C. Goodnow, J. Crosbie, H. Jorgensen, R. A. Brink, A. Basten, Induction of self-tolerance in mature peripheral B lymphocytes. Nature 342, 385-391 (1989).
26. S. M. Alam, H.-X. Liao, S. M. Dennison, F. Jaeger, R. Parks, K. Anasti, A. Foulger, M. Donathan, J. Lucas, L. Verkoczy, N. Nicely, G. D. Tomaras, G. Kelsoe, B. Chen, T. B. Kepler, B. F. Haynes, Differential reactivity of germ line allelic variants of a broadly neutralizing HIV-1 antibody to a gp41 fusion intermediate conformation. J. Virol. 85, 11725-11731 (2011).
27. M. Kim, Z.-Y. Sun, K. D. Rand, X. Shi, L. Song, Y. Cheng, A. F. Fahmy, S. Majumdar, G. Ofek, Y. Yang, P. D. Kwong, J.-H. Wang, J. R. Engen, G. Wagner, E. L. Reinherz, Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization. Nat. Struct. Mol. Biol. 18, 1235-1243 (2011).
28. G. Ofek, M. Tang, A. Sambor, H. Katinger, J. R. Mascola, R. Wyatt, P. D. Kwong, Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope. J. Virol. 78, 10724-10737 (2004).
29. M.-Y. Zhang, X. Xiao, I. A. Sidorov, V. Choudhry, F. Cham, P. F. Zhang, P. Bouma, M. Zwick, A. Choudhary, D. C. Montefiori, C. C. Broder, D. R. Burton, G. V. Quinnan Jr., D. S. Dimitrov, Identification and characterization of a new cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody. J. Virol. 78, 9233-9242 (2004).
30. L. Morris, X. Chen, M. Alam, G. Tomaras, R. Zhang, D. J. Marshall, B. Chen, R. Parks, A. Foulger, F. Jaeger, M. Donathan, M. Bilska, E. S. Gray, S. S. Abdool Karim, T. B. Kepler, J. Whitesides, D. Montefiori, M. A. Moody, H.-X. Liao, B. F. Haynes, Isolation of a human anti-HIV gp41 membrane proximal region neutralizing antibody by antigen-specific single B cell sorting. PLOS One 6, e23532 (2011).
31. L. G. Perez, M. R. Costa, C. A. Todd, B. F. Haynes, D. C. Montefiori, Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: A specific role for antibodies against the membrane-proximal external region of gp41. J. Virol. 83, 7397-7410 (2009).
32. X. Shen, S. M. Dennison, P. Liu, F. Gao, F. Jaeger, D. C. Montefiori, L. Verkoczy, B. F. Haynes, S. M. Alam, G. D. Tomaras, Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution. Proc. Natl. Acad. Sci. U.S.A. 107, 5972-5977 (2010).
33. G. Frey, J. Chen, S. Rits-Volloch, M. M. Freeman, S. Zolla-Pazner, B. Chen, Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies. Nat. Struct. Mol. Biol. 17, 1486-1491 (2010).
34. A. S. Dimitrov, A. Jacobs, C. M. Finnegan, G. Stiegler, H. Katinger, R. Blumenthal, Exposure of the membrane-proximal external region of HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion. Biochemistry 46, 1398-1401 (2007).
35. E. Gustchina, C. A. Bewley, G. M. Clore, Sequestering of the prehairpin intermediate of gp41 by peptide N36Mut(e,g) potentiates the human immunodeficiency virus type 1 neutralizing activity of monoclonal antibodies directed against the N-terminal helical repeat of gp41. J. Virol. 82, 10032-10041 (2008).
36. A. Zhen, S. R. Krutzik, B. R. Levin, S. Kasparian, J. A. Zack, S. G. Kitchen, CD4 ligation on human blood monocytes triggers macrophage differentiation and enhances HIV infection. J. Virol. 88, 9934-9946 (2014).
37. W. C. Wimley, S. H. White, Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat. Struct. Biol. 3, 842-848 (1996).
38. G. Ofek, B. Zirkle, Y. Yang, Z. Zhu, K. McKee, B. Zhang, G.-Y. Chuang, I. S. Georgiev, S. O'Dell, N. Doria-Rose, J. R. Mascola, D. S. Dimitrov, P. D. Kwong, Structural basis for HIV-1 neutralization by 2F5-like antibodies m66 and m66.6. J. Virol. 88, 2426-2441 (2014).
39. S. H. Northrup, H. P. Erickson, Kinetics of protein-protein association explained by Brownian dynamics computer simulation. Proc. Natl. Acad. Sci. U.S.A. 89, 3338-3342 (1992).
40. J. Foote, H. N. Eisen, Kinetic and affinity limits on antibodies produced during immune responses. Proc. Natl. Acad. Sci. U.S.A. 92, 1254-1256 (1995).
41. H.-P. Roost, M. F. Bachmann, A. Haag, U. Kalinke, V. Pliska, H. Hengartner, R. M. Zinkernagel, Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity. Proc. Natl. Acad. Sci. U.S.A. 92, 1257-1261 (1995).
42. T. L. O'Keefe, G. T. Williams, F. D. Batista, M. S. Neuberger, Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 189, 1307-1313 (1999).
43. B. F. Haynes, L. Verkoczy, G. Kelsoe, Redemption of autoreactive B cells. Proc. Natl. Acad. Sci. U.S.A. 111, 9022-9023 (2014).
44. Z. Sabouri, P. Schofield, K. Horikawa, E. Spierings, D. Kipling, K. L. Randall, D. Langley, B. Roome, R. Vazquez-Lombardi, R. Rouet, J. Hermes, T. D. Chan, R. Brink, D. K. Dunn-Walters, D. Christ, C. C. Goodnow, Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity. Proc. Natl. Acad. Sci. U.S.A. 111, E2567-E2575 (2014).
45. M. Locci, C. Havenar-Daughton, E. Landais, J. Wu, M. A. Kroenke, C. L. Arlehamn, L. F. Su, R. Cubas, M. M. Davis, A. Sette, E. K. Haddad; International AIDS Vaccine Initiative Protocol C Principal Investigators, P. Poignard, S. Crotty, Human circulating PD-1+CXCR3-CXCR5+ memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses. Immunity 39, 758-769 (2013).
46. S. Crotty, T follicular helper cell differentiation, function, and roles in disease. Immunity 41, 529-542 (2014).
47. E. Meffre, M. Milili, C. Blanco-Betancourt, H. Antunes, M. C. Nussenzweig, C. Schiff, Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development. J. Clin. Invest. 108, 879-886 (2001).
48. L. Verkoczy, M. A. Moody, T. M. Holl, H. Bouton-Verville, R. M. Scearce, J. Hutchinson, S. M. Alam, G. Kelsoe, B. F. Haynes, Functional, non-clonal IgMa-restricted B cell receptor interactions with the HIV-1 envelope gp41 membrane proximal external region. PLOS One 4, e7215 (2009).
49. S. Santra, H.-X. Liao, R. Zhang, M. Muldoon, S. Watson, W. Fischer, J. Theiler, J. Szinger, H. Balachandran, A. Buzby, D. Quinn, R. J. Parks, C.-Y. Tsao, A. Carville, K. G. Mansfield, G. N. Pavlakis, B. K. Felber, B. F. Haynes, B. T. Korber, N. L. Letvin, Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys. Nat. Med. 16, 324-328 (2010).
50. M. A. Moody, S. Santra, N. A. Vandergrift, L. L. Sutherland, T. C. Gurley, M. S. Drinker, A. A. Allen, S.-M. Xia, R. R. Meyerhoff, R. Parks, K. E. Lloyd, D. Easterhoff, S. M. Alam, H.-X. Liao, B. M. Ward, G. Ferrari, D. C. Montefiori, G. D. Tomaras, R. A. Seder, N. L. Letvin, B. F. Haynes, Toll-like receptor 7/8 (TLR7/8) and TLR9 agonists cooperate to enhance HIV-1 envelope antibody responses in rhesus macaques. J. Virol. 88, 3329-3339 (2014).
51. S. M. Dennison, L. L. Sutherland, F. H. Jaeger, K. M. Anasti, R. Parks, S. Stewart, C. Bowman, S.-M. Xia, R. Zhang, X. Shen, R. M. Scearce, G. Ofek, Y. Yang, P. D. Kwong, S. Santra, H.-X. Liao, G. Tomaras, N. L. Letvin, B. Chen, S. M. Alam, B. F. Haynes, Induction of antibodies in rhesus macaques that recognize a fusion-intermediate conformation of HIV-1 gp41. PLOS One 6, e27824 (2011).
52. K. Wiehe, D. Easterhoff, K. Luo, N. I. Nicely, T. Bradley, F. H. Jaeger, S. M. Dennison, R. Zhang, K. E. Lloyd, C. Stolarchuk, R. Parks, L. L. Sutherland, R. M. Scearce, L. Morris, J. Kaewkungwal, S. Nitayaphan, P. Pitisuttithum, S. Rerks-Ngarm, F. Sinangil, S. Phogat, N. L. Michael, J. H. Kim, G. Kelsoe, D. C. Montefiori, G. D. Tomaras, M. Bonsignori, S. Santra, T. B. Kepler, S. M. Alam, M. A. Moody, H.-X. Liao, B. F. Haynes, Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conserved. Immunity 41, 909-918 (2014).
53. H.-X. Liao, M. C. Levesque, A. Nagel, A. Dixon, R. Zhang, E. Walter, R. Parks, J. Whitesides, D. J. Marshall, K.-K. Hwang, Y. Yang, X. Chen, F. Gao, S. Munshaw, T. B. Kepler, T. Denny, M. A. Moody, B. F. Haynes, High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J. Virol. Methods 158, 171-179 (2009).
54. Cloanalyst. http://www.bu.edu/computationalimmunology/research/software/.
55. T. B. Kepler, Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors [version 1; referees: 2 approved, 1 approved with reservations]. F1000Res 2, 103 (2013).
56. T. B. Kepler, S. Munshaw, K. Wiehe, R. Zhang, J.-S. Yu, C. W. Woods, T. N. Denny, G. D. Tomaras, S. M. Alam, M. A. Moody, G. Kelsoe, H.-X. Liao, B. F. Haynes, Reconstructing a B-cell clonal lineage. II. Mutation, selection, and affinity maturation. Front. Immunol. 5, 170 (2014).
57. C. Snider, S. Jayasinghe, K. Hristova, S. H. White, MPEx: A tool for exploring membrane proteins. Protein Sci. 18, 2624-2628 (2009).
58. Y. Benjamini, Y. Hochberg, Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. B Met. 57, 289-300 (1995).
59. H.-X. Liao, M. Bonsignori, S. M. Alam, J. S. McLellan, G. D. Tomaras, M. A. Moody, D. M. Kozink, K.-K. Hwang, X. Chen, C.-Y. Tsao, P. Liu, X. Lu, R. J. Parks, D. C. Montefiori, G. Ferrari, J. Pollara, M. Rao, K. K. Peachman, S. Santra, N. L. Letvin, N. Karasavvas, Z.-Y. Yang, K. Dai, M. Pancera, J. Gorman, K. Wiehe, N. I. Nicely, S. Rerks-Ngarm, S. Nitayaphan, J. Kaewkungwal, P. Pitisuttithum, J. Tartaglia, F. Sinangil, J. H. Kim, N. L. Michael, T. B. Kepler, P. D. Kwong, J. R. Mascola, G. J. Nabel, A. Pinter, S. Zolla-Pazner, B. F. Haynes, Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. Immunity 38, 176-186 (2013).
60. M. J. Root, M. S. Kay, P. S. Kim, Protein design of an HIV-1 entry inhibitor. Science 291, 884-888 (2001).
61. N. L. Yates, A. R. Stacey, T. L. Nolen, N. A. Vandergrift, M. A. Moody, D. C. Montefiori, K. J.Weinhold, W. A. Blattner, P. Borrow, R. Shattock, M. S. Cohen, B. F. Haynes, G. D. Tomaras, HIV-1 gp41 envelope IgA is frequently elicited after transmission but has an initial short response half-life. Mucosal Immunol. 6, 692-703 (2013).
62. G. D. Tomaras, N. L. Yates, P. Liu, L. Qin, G. G. Fouda, L. L. Chavez, A. C. Decamp, R. J. Parks, V. C. Ashley, J. T. Lucas, M. Cohen, J. Eron, C. B. Hicks,H.-X. Liao, S.G. Self, G. Landucci, D. N. Forthal, K. J. Weinhold, B. F. Keele, B. H. Hahn, M. L. Greenberg, L. Morris, S. S. Karim, W. A. Blattner, D. C. Montefiori, G. M. Shaw, A. S. Perelson, B. F. Haynes, Initial B-cell responses to transmitted human immunodeficiency virus type 1: Virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia. J. Virol. 82, 12449-12463 (2008).
63. M. A. Moody, N. L. Yates, J. D. Amos, M. S. Drinker, J. A. Eudailey, T. C. Gurley, D. J. Marshall, J. F. Whitesides, X. Chen, A. Foulger, J. S. Yu, R. Zhang, R. R. Meyerhoff, R. Parks, J. C. Scull, L.Wang, N. A. Vandergrift, J. Pickeral, J. Pollara, G. Kelsoe, S. M. Alam, G. Ferrari, D. C. Montefiori, G. Voss, H. X. Liao, G. D. Tomaras, B. F. Haynes, HIV-1 gp120 vaccine induces affinity maturation in both new and persistent antibody clonal lineages. J. Virol. 86, 7496-7507 (2012).
64. S. M. Dennison, K. Anasti, R. M. Scearce, L. Sutherland, R. Parks, S.-M. Xia, H.-X. Liao, M. K. Gorny, S. Zolla-Pazner, B. F. Haynes, S. M. Alam, Nonneutralizing HIV-1 gp41 envelope cluster II human monoclonal antibodies show polyreactivity for binding to phospholipids and protein autoantigens. J. Virol. 85, 1340-1347 (2011).
65. M. Li, F. Gao, J. R. Mascola, L. Stamatatos, V. R. Polonis, M. Koutsoukos, G. Voss, P. Goepfert, P. Gilbert, K. M. Greene, M. Bilska, D. L. Kothe, J. F. Salazar-Gonzalez, X.Wei, J. M.Decker, B. H. Hahn, D. C. Montefiori, Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79, 10108-10125 (2005).
66. G. H. Bird, A. Irimia, G. Ofek, P. D. Kwong, I. A. Wilson, L. D. Walensky, Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies. Nat. Struct. Mol. Biol. 21, 1058-1067 (2014).
67. A. Otwinowski, W. Minor, Processing of X-ray diffraction data collected in oscillation model. Methods Enzymol. 276, 307-326 (1997).
68. B. W. Matthews, Solvent content of protein crystals. J. Mol. Biol. 33, 491-497 (1968).
69. T. C. Terwilliger, R. W. Grosse-Kunstleve, P. V. Afonine, N. W. Moriarty, P. H. Zwart, L.-W. Hung, R. J. Read, P. D. Adams, Iterative model building, structure refinement and density modification with the PHENIX AutoBuild wizard. Acta Crystallogr. D Biol. Crystallogr. 64 (Pt. 1), 61-69 (2008).
70. B. Spurrier, J. M. Sampson, M. Totrov, H. Li, T. O'Neal, C. Williams, J. Robinson, M. K. Gorny, S. Zolla-Pazner, X. P. Kong, Structural analysis of human and macaque mAbs 2909 and 2.5B: Implications for the configuration of the quaternary neutralizing epitope of HIV-1 gp120. Structure 19, 691-699 (2011).
71. B. A. Appleton, P. Wu, J. Maloney, J. Yin, W.-C. Liang, S. Stawicki, K. Mortara, K. K. Bowman, J. M. Elliott, W. Desmarais, J. F. Bazan, A. Bagri, M. Tessier-Lavigne, A. W. Koch, Y. Wu, R. J. Watts, C. Wiesmann, Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding. EMBO J. 26, 4902-4912 (2007).
72. P. Emsley, B. Lohkamp, W. G. Scott, K. Cowtan, Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66 (Pt. 4), 486-501 (2010).
73. P. D. Adams, P. V. Afonine, G. Bunkóczi, V. B. Chen, I. W. Davis, N. Echols, J. J. Headd, L.-W. Hung, G. J. Kapral, R. W.Grosse-Kunstleve, A. J. McCoy,N. W.Moriarty, R.Oeffner, R. J. Read, D. C. Richardson, J. S. Richardson, T. C. Terwilliger, P. H. Zwart, PHENIX: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr.D Biol. Crystallogr. 66 (Pt. 2), 213-221 (2010).
74. S. C. Lovell, I. W. Davis, W. B. Arendall III, P. I. W. de Bakker, J. M. Word, M. G. Prisant, J. S. Richardson, D. C. Richardson, Structure validation by Ca geometry: f,y and Cb deviation. Proteins 50, 437-450 (2003).